Clinical Trials Browser

Phase 3 × Not yet recruiting × daratumumab × Clear all

NCT07623798 2026-06-03

A Study in Participants With Relapsed or Refractory Multiple Myeloma for IBI3003

Phase 3 Not yet recruiting

Multiple Myeloma, Recurrence

NCT07393282 2026-03-16

LINKER-SMM2

Phase 3 Not yet recruiting

Smoldering Multiple Myeloma, Multiple Myeloma